The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
Liraglutide is a synthetic GLP-1 receptor agonist studied in laboratory research exploring incretin signaling pathways and metabolic regulatory mechanisms.